Solventum
Overview
Solventum (NYSE: SOLV) is a global healthcare company spun off from 3M on April 1, 2024, focusing on medical-surgical, dental, health information systems, and purification products. With ~$8.25 billion in annual revenue, it aims to deliver innovative, data-driven solutions—such as V.A.C. Therapy and Littmann stethoscopes—to improve patient outcomes.
Founded Year
2023
Ownership Type
Privately Held
Business Model
B2B (Business to Business)
Time Zone
GMT - 5
Mission
Enabling Better, Smarter, Safer Healthcare
Vision
Shaping the Future of Health
Core Values
Company Tagline
Head Office Country
United States